Webinar
First Look: 2025 Perceptions and Insights Study
Discover key findings from our 2025 study with over 12,000 responses from around the world.
About the Event
CISCRP’s Perceptions & Insights Study is the largest global assessment of public and patient perceptions, motivations, and experiences with clinical research. Our webinar will include first-look access to the results, discussion between the professionals that gathered and analyzed the data, and key findings of this year’s study that will be released in November 2025.
Date & Time
October 21, 2025
11:00 am - 12:00 pm EDT
Meet the Panel
Ken Getz
Founder & Board Chair · CISCRP
Annick de Bruin
Chief Research & Insights Officer, Research Services · CISCRP
Shalome Sine
Senior Manager & Quantitative Insights Specialist, Research Services · CISCRP
Allison Kuban
Allison Kuban was diagnosed with stage-4 Pancreatic Cancer on her 31st birthday. By the power of prayer and miracles of science, Allison is a 8-year survivor. After the unexpected diagnosis, she left her career in hospitality management to focus on her health and spend time enjoying the things she loves: family; traveling with her husband Eric; and playing with their Goldendoodle, Banks. Allison has spent the last several years advocating for genetic testing and medical research.
Ashley Ann Lora
Ashley Ann Lora is a nationally recognized patient advocate, speaker, and consultant who has lived with multiple forms of eczema for over 30 years. With firsthand experience navigating the physical, emotional, and social challenges of atopic dermatitis, Ashley has made it her mission to bridge the gap between patients, healthcare professionals, and industry leaders. She collaborates with pharmaceutical and healthcare organizations to improve patient engagement, shares educational content across social media, and leads monthly support groups to uplift and empower the eczema community. Ashley’s work has been featured on Dr. Phil, Sharecare, WebMD, National Eczema Association and so much more.
Key Findings from this Year's Study
Helping others is the #1 reason people join clinical trials.
As in past years, altruistic drivers continue to be the top reasons for participation in clinical trials, with 50% participating to help advance science and 40% participating to help others who may suffer from their same disease/condition.
Social media can be a gateway to clinical research
1 in 5 clinical trial participants first learned about the participation opportunity online, most often via social media.
Trust in pharma lags behind other organizations involved in clinical research
Only 18% trust pharma companies ‘A lot,’ compared to 46% who trust site staff and healthcare providers ‘A lot.’
Be the first to know when 2025 study is live
Sign-up for updates to be notified when our global study is released in November showcasing new public perceptions, motivations, and experiences with clinical research.